Century Therapeutics, Inc.
IPSC
$2.21
$0.094.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.90% | 44.32% | -5.80% | -142.50% | 312.24% |
| Total Depreciation and Amortization | -15.38% | 13.45% | -2.25% | -0.62% | -2.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.24% | -155.51% | 165.50% | 35.62% | -73.02% |
| Change in Net Operating Assets | -304.21% | 497.23% | -12.93% | 99.39% | -6,450.38% |
| Cash from Operations | -57.13% | 37.16% | 7.28% | 20.31% | -42.93% |
| Capital Expenditure | -520.14% | 171.28% | 38.49% | 33.26% | -208.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -604.14% | -10.63% | -24.32% | 15.67% | -7.72% |
| Cash from Investing | -603.62% | -9.36% | -24.18% | 16.50% | -8.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 238,811.32% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 238,811.32% | -- | -- | -100.00% | 119.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.59% | 794.09% | -118.46% | 175.26% | -213.70% |